mirtazapine has been researched along with Kidney Failure, Chronic in 3 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tacrolimus blood levels were higher than 15 ng/ml." | 5.35 | Hypotension, as consequence of the interaction between tacrolimus and mirtazapine, in a patient with renal transplant. ( Alvarez, M; Corbacho, L; Fraile, P; Garcia, T; Garcia-Cosmes, P; Tabernero, JM, 2009) |
| "An 83-year-old man with chronic renal failure was referred to our hospital because of subacute progressive right hemiparesis." | 1.43 | A case of progressive multifocal leukoencephalopathy with chronic renal failure, whose JC virus in cerebrospinal fluid disappeared after mefloquine-mirtazapine dual therapy. ( Asayama, S; Asayama, T; Kosaka, S; Nakamichi, K; Ohnuki, E; Saijo, M, 2016) |
| "Tacrolimus blood levels were higher than 15 ng/ml." | 1.35 | Hypotension, as consequence of the interaction between tacrolimus and mirtazapine, in a patient with renal transplant. ( Alvarez, M; Corbacho, L; Fraile, P; Garcia, T; Garcia-Cosmes, P; Tabernero, JM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohnuki, E | 1 |
| Asayama, S | 1 |
| Asayama, T | 1 |
| Nakamichi, K | 1 |
| Saijo, M | 1 |
| Kosaka, S | 1 |
| Fraile, P | 1 |
| Garcia-Cosmes, P | 1 |
| Garcia, T | 1 |
| Corbacho, L | 1 |
| Alvarez, M | 1 |
| Tabernero, JM | 1 |
| Rodriguez-Pecci, MS | 1 |
| Fuente-Aguado, Jde L | 1 |
| Montero-Tinnirello, J | 1 |
| Fernandez-Fernandez, FJ | 1 |
3 other studies available for mirtazapine and Kidney Failure, Chronic
| Article | Year |
|---|---|
A case of progressive multifocal leukoencephalopathy with chronic renal failure, whose JC virus in cerebrospinal fluid disappeared after mefloquine-mirtazapine dual therapy.
Topics: Aged, 80 and over; Astrocytes; Brain; Cerebrospinal Fluid; Drug Therapy, Combination; Humans; Immuno | 2016 |
Hypotension, as consequence of the interaction between tacrolimus and mirtazapine, in a patient with renal transplant.
Topics: Aged; Antidepressive Agents, Tricyclic; Blood Pressure; Depressive Disorder; Drug Interactions; Fema | 2009 |
[Mirtazapine-associated hepatotoxicity].
Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Depressive Disorder; Dru | 2010 |